"Avoidable Deaths" - Union for International Cancer Control
"Back to Basics: The Concept of HRQL Under a Magnifying Glass" - EORTC Quality of Life Group
"Bald for a Cause" initiative - UWC Dilijan College
Naveen Pemmaraju shares new report on oral DAC+VEN for BPDCN published in Leukemia and Lymphoma Journal
Regina Barragan-Carrillo: Latin American representation was strong at the PCF Early Career Thought Leaders
Daniel Chen and Synthetic Design Lab announce $20M launch to advance ADC innovation
Amer Zeidan: Matteo Della Porta about used of artificial intelligence in hematologic malignancies
Julie McCrossin AM: I am frustrated at the delay in Australians getting access to proton therapy for oropharyngeal cancer
Gate2Brain has reached a major milestone as its innovative drug, G2B-002, has received Orphan Drug Designation
